copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Register as a Client – Muscular Dystrophy Canada In order to receive services or financial assistance from Muscular Dystrophy Canada, your first step is to register with us as a client To register, you must have a confirmed diagnosis of a neuromuscular disorder under the Muscular Dystrophy umbrella, signed by a physician or a health professional
Myotonic Dystrophy - Muscular Dystrophy Canada Myotonic Dystrophy or dystrophia myotonica (DM) is a genetic disease characterized by progressive muscle degeneration DM is divided into two types: type 1 affects a gene called DMPK on chromosome 19, and type 2 affects a gene on chromosome 3 called ZNF9
Duchenne - Muscular Dystrophy Canada Duchenne Muscular Dystrophy (DMD) is a genetic disease characterized by a progressive muscle degeneration It is caused by an absence of dystrophin, a protein that supports the integrity of muscle cells Symptoms are usually detected in early childhood
Events - Muscular Dystrophy Canada Upcoming Events Muscular Dystrophy Canada (MDC) is monitoring air quality concerns as a result of wildfires across Canada We are using Environment Canada information for monitoring and decision-making purposes Our commitment is to ensure that all MDC hosted events are safe and inclusive for all
Research - Muscular Dystrophy Canada Funding cutting-edge neuromuscular research has always been a priority for Muscular Dystrophy Canada We support research here in Canada, as well as internationally, through our partnership with the Canadian Institute for Health Research (CIHR)
Spinal Muscular Atrophy - Muscular Dystrophy Canada Spinal Muscular Atrophy (SMA) is an autosomal recessive genetic disorder SMA affects the muscles throughout the body—but it’s the proximal muscles, those closest to the trunk of the body, such as the shoulders, hips, and back, that are most severely affected
Need Help? - Muscular Dystrophy Canada Call 1-800-567-2873 ext 1114 or email research@muscle ca and our research team will provide you with accurate and timely answers There is no such thing as a silly question! Canadians impacted by neuromuscular disorders need your help
Newborn Screening - Muscular Dystrophy Canada Newborn Screening In December 2020, MDC launched a multi-year, multi-phase endeavour in collaboration with Novartis Pharmaceuticals Canada Inc to better understand and address barriers for the implementation of newborn screening for spinal muscular atrophy (SMA)
Walk and Roll | Home - Muscular Dystrophy Canada By participating in the Walk and Roll for Muscular Dystrophy Canada and raising funds, you’re helping individuals affected by neuromuscular disorders get the right diagnosis and access treatment as early as possible
Financial Statements - Muscular Dystrophy Canada Muscular Dystrophy Canada’s financial activities are conducted in a responsible manner, which fulfils our commitment of accountability and transparency to our stakeholders Complete audited financial statements are also available upon request